California firefighter accused of sparking blazes in the state's wine country
GM to lay off about 1,700 workers at Kansas plant
Ireland drops plans for hate speech law, minister says
US not responsible for violence in Mexico's Sinaloa state, ambassador says
Russian strike on apartment block in Kharkiv injures 12
Tens of thousands of bees found living in a Maine family’s farmhouse
Sullivan expresses worry over escalating Israel-Lebanon tension, calls Hezbollah strike as justice served
No. 3 Ohio State looks ahead to Big Ten schedule after rolling through nonconference games
Garrett Greene throws two late TD passes and West Virginia beats Kansas 32-28
Dubois beats up Joshua to retain IBF heavyweight title with 5th-round knockout
(Reuters) -Kenvue beat Wall Street estimates for second-quarter profit and revenue on Tuesday, helped primarily by better-than-expected sales in its essential health products unit that sells brands including Band-Aid, Listerine and Carefree.
Shares of the company rose 4.7% to $19.05 in premarket trading.
Investor expectations from the consumer health company, which Johnson & Johnson spun off last year, have been low due to weak uptake for its self-care and skin health products. Its essential health business, however, has been a bright spot.
The essential health unit recorded $1.26 billion in revenue for the second quarter, up nearly 5% from a year earlier and above analysts' average estimate of $1.24 billion, according to LSEG data.
Essential health's adjusted operating income jumped nearly 44% to $359 million, while other segments declined.
Kenvue's skin health business, which sells brands such as Neutrogena and Clean & Clear, was the worst performer, recording a nearly 4% decline in sales to $1.10 billion, compared with LSEG estimate of $1.16 billion.
Sales from self-care - its largest segment that houses Benadryl and Tylenol - slipped 1.6% to $1.64 billion. Analysts, on average, had expected $1.60 billion.
Kenvue has been focusing on improving sales of its skin health products through increased marketing spend and in-store presence, among other measures.
It raised the marketing spend for this year to up to $400 million from $300 million previously. It's the second time it lifted the forecast, after a 15% jump in February.
The New Jersey-based company posted total second-quarter revenue of $4 billion, above LSEG estimates of $3.94 billion.
On an adjusted basis, Kenvue posted a profit of 32 cents per share, beating analysts' estimates by 4 cents.
The company maintained its adjusted profit forecast for the year at between $1.10 and $1.20 per share.
(Reporting by Sneha S K and Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)
